Pharmacokinetic study of a sulfametopyrazine/trimethoprim combination (Kelfiprim) in human volunteers. - Suppr | 超能文献

Pharmacokinetic study of a sulfametopyrazine/trimethoprim combination (Kelfiprim) in human volunteers.

作者信息

Reeves D S, Bywater M J, Bullock D W, Holt H A

出版信息

J Antimicrob Chemother. 1980 Sep;6(5):647-56. doi: 10.1093/jac/6.5.647.

DOI:10.1093/jac/6.5.647

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pharmacokinetic study of a sulfametopyrazine/trimethoprim combination (Kelfiprim) in human volunteers.

J Antimicrob Chemother. 1980 Sep;6(5):647-56. doi: 10.1093/jac/6.5.647.

2

Distribution of trimethoprim and sulfametopyrazine in the female reproductive tract.甲氧苄啶和磺胺甲氧嗪在女性生殖道中的分布。

J Int Med Res. 1986;14(2):101-4. doi: 10.1177/030006058601400209.

3

Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.人血清和唾液中甲氧苄啶-磺胺甲基吡嗪组合的水平。

Eur J Clin Pharmacol. 1981;20(2):113-8. doi: 10.1007/BF00607146.

4

Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency.新磺胺甲吡嗪-甲氧苄啶复方制剂（凯尔菲普明）在肾功能不全患者中的药代动力学研究

Eur J Clin Pharmacol. 1984;27(3):345-8. doi: 10.1007/BF00542173.

5

[Serum levels and urinary excretion of trimethoprim and sulfamethoxypyrazine after combined administration in man].[人联合服用甲氧苄啶和磺胺甲氧嗪后的血清水平及尿排泄情况]

Farmaco Prat. 1977 May;32(5):228-37.

6

[Pharmacokinetic aspects of a pyrimethamine combination with sulfanilamides].乙胺嘧啶与磺胺类药物联合应用的药代动力学方面

Med Parazitol (Mosk). 1986 Jul-Aug(4):10-5.

7

Agranulocytosis and anaemia induced by sulfametopyrazine in a sulfametopyrazine-trimethoprim combination.磺胺甲氧嗪-甲氧苄啶组合中磺胺甲氧嗪诱发的粒细胞缺乏症和贫血

Ann Acad Med Singap. 1989 May;18(3):307-10.

8

[Pharmacokinetic studies on treatment with sulfonamides and trimethoprim].

Tidsskr Nor Laegeforen. 1981 Apr 20;101(11):637-40.

9

[Pharmacokinetic characteristics of 2-sulfamilamido-3-methoxypyrazine. Blood and tissue levels in patients undergoing surgical operations].[2-磺胺氨基-3-甲氧基吡嗪的药代动力学特征。外科手术患者的血液和组织水平]

Atti Accad Med Lomb. 1973;28(1-4):69-74.

10

Kelfiprim. A new sulfa-trimethoprim combination in urinary tract infections.凯尔菲普明。一种用于治疗尿路感染的新型磺胺甲恶唑复方制剂。

J Med Assoc Thai. 1985 Jul;68(7):342-6.

引用本文的文献

1

Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.人血清和唾液中甲氧苄啶-磺胺甲基吡嗪组合的水平。

Eur J Clin Pharmacol. 1981;20(2):113-8. doi: 10.1007/BF00607146.

2

Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind trial.新型磺胺甲恶唑复方制剂凯尔氟普明与复方新诺明治疗尿路感染的多中心双盲试验

Urol Res. 1982 Feb;10(1):41-4. doi: 10.1007/BF00256523.

3

Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency.新磺胺甲吡嗪-甲氧苄啶复方制剂（凯尔菲普明）在肾功能不全患者中的药代动力学研究

Eur J Clin Pharmacol. 1984;27(3):345-8. doi: 10.1007/BF00542173.

4

Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.抗菌化疗中酶抑制剂的临床药代动力学

Clin Pharmacokinet. 1988 Sep;15(3):133-64. doi: 10.2165/00003088-198815030-00001.